๐ข Recruiting
Phase 1
๐ Investigational Drug / Biologic
NCT06706076
A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations
๐ Mayo Clinic Hospital - Arizona โ Phoenix, Arizona
View Study & Checklist โ